It is applied when a patient is shedding weight unwittingly, and the cause of the problem might not be identified
UroMems CEO and Co-founder Hamid Lamraoui Continued successful results will lead to UroMems' pivotal clinical trial in Europe and the U.S
After eating, GLP-1 is released into the bloodstream and works through several mechanisms to maintain blood sugar levels and promote satiety (the feeling of fullness)
Then, as now, choosing a GLP-1 drug will involve weighing the relative importance of weight loss and blood sugar management for improving ones health
In April 2025, the Trump administration reversed a Biden-era decision and announced that Medicare would no longer cover GLP-1 medications specifically for weight loss
Clinical Implications & What I Might Recommend If you are interested in whether GLP-1 drugs might be protective for your brain, heres how Id think about integrating the current data into individualized care